Meropenem

500 mg every 8 hours by intravenous infusion over 15 to 30 minutes for complicated skin and skin structure infections (cSSSI) for adult patients. When treating infections caused by Pseudomonas aeruginosa, a dose of 1 gram every 8 hours is recommended. 1 gram every 8 hours by intravenous infusion over 15 minutes to 30 minutes for intra-abdominal infections for adult patients.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Meropenem for Injection, USP is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta (β)-lactams. Known hypersensitivity to product components or anaphylactic reactions to β-lactams.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving β-lactams. Severe cutaneous adverse reactions have been reported in patients receiving Meropenem for Injection, USP. Seizures and other adverse CNS experiences have been reported during treatment. Co-administration of Meropenem for Injection, USP with valproic acid or divalproex sodium reduces the serum concentration of valproic acid potentially increasing the risk of breakthrough seizures. Clostridium difficile- associated diarrhea (ranging from mild diarrhea to fatal colitis) has been reported.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following are discussed in greater detail in other sections of labeling: Hypersensitivity Reactions Severe Cutaneous Adverse Reactions Seizure Potential Risk of Breakthrough Seizures Due to Drug Interaction with Valproic Acid Clostridium difficile – associated Diarrhea Development of Drug-Resistant Bacteria Overgrowth of Nonsusceptible Organisms Thrombocytopenia Potential for Neuromotor Impairment Most common adverse…

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

1016 products from 626 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 1016 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Conditions Store at 20° to 25°C (68° to 77°F). Sterile, Nonpyrogenic, Preservative-free. The container closure is not made with natural rubber latex.

Storage information from the U.S. FDA-approved label.